Crossmark

Disturbance of serum lipid metabolites and potential biomarkers in the Bleomycin model of pulmonary fibrosis in young mice

Published Online: 2022-05-04

Published Print: 2022-12

Authors

Yang, Xiao-hui

Wang, Fang-fang

Chi, Xiao-sa

Wang, Xiao-meng

Cong, Jin-peng

Hu, Yi

Zhang, Yu-zhu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81901321, 82000268)

Natural Science Foundation of Shandong Province (ZR202103030823)
License Information

Text and Data Mining valid from 2022-05-04

Version of Record valid from 2022-05-04
More Information

Article History

Received: 12 December 2021

Accepted: 26 April 2022

First Online: 4 May 2022

Declarations

:

: All experiments were approved by the Ethics Committee of Affiliated Hospital of Qingdao University (Ethics No. QYFYW2LL26275), and all methods were carried out following relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines ().

: Not applicable.

: The authors declare that they have no competing interests.

Document is current